当前位置: 首页 > 期刊 > 《中国现代医生》 > 2017年第35期
编号:13207257
隐丹参酮对乳腺癌MDA—MB—231细胞迁移、侵袭的影响及其机制(5)
http://www.100md.com 2017年12月15日 中国现代医生 2017年第35期
     [16]Liu HY,Gu WJ,Wang CZ,et al.Matrix metalloproteinase-9 and-2 and tissue inhibitor of matrix metalloproteinase-2 in invasive pituitary adenomas:A systematic review and meta-analysis of case-control trials[J]. Medicine (Baltimore),2016,95(24):e3904.

    [17]Salmaninejad A,Zamani MR,Pourvahedi M,et al. Cancer/testis antigens:Expression,regulation,tumor invasion,and use in immunotherapy of cancers[J]. Immunol Invest,2016,45(7):619-640.

    [18]Wang HL,Zhou PY,Zhang Y,et al.Relationships between abnormal MMP2 expression and prognosis in gastric cancer:A meta-analysis of cohort studies[J].Cancer Biother Radiopharm,2014,29(4):166-172.

    [19]Liu Y,Zhu P,Wang Y,et al. Antimetastatic therapies of the polysulfide diallyl trisulfide against triple-negative breast cancer(TNBC) via suppressing MMP2/9 by blocking NF-kappaB and ERK/MAPK signaling pathways[J]. PLoS One,2015,10(4):e0123781.

    [20]Byun HJ,Darvin P,Kang DY,et al. Silibinin downregulates MMP2 expression via Jak2/STAT3 pathway and inhibits the migration and invasive potential in MDA-MB-231 cells[J]. Oncol Rep,2017,37(6):3270-3278.

    (收稿日期:2017-09-11), 百拇医药(周南阳 赵虹)
上一页1 2 3 4 5